Related Experiment Video
Updated: Aug 14, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Pediatric research 'personalized'? International perspectives on the return of results
Bartha Maria Knoppers1, Amélie Rioux2, Ma'n H Zawati2
1Centre of Genomics & Policy, McGill University/Genome Quebec Innovation Centre, Montréal (Québec), Canada. bartha.knoppers@mcgill.ca.
Insights
New sequencing technologies challenge the
Area of Science:
- Pediatric research ethics
- Genomic medicine
- Bioethics
Background:
- The principle of 'best interests of the child' traditionally guides pediatric research decision-making.
- Advancements in sequencing technologies introduce complexities regarding the return of research results and incidental findings.
- Existing ethical frameworks require re-evaluation in light of personalized medicine.
Purpose of the Study:
- To analyze international and national approaches to returning research results and incidental findings in pediatric research.
- To examine how new sequencing technologies impact decision-making principles in pediatric research.
- To identify emerging pediatric policy trends concerning personalized genetic information.
Main Methods:
- Comparative analysis of policies in the USA, Canada, France, Spain, and the UK.
- Review of legal and ethical guidelines related to pediatric research and genetic testing.
- Examination of case studies on the return of incidental findings in childhood.
Main Results:
- Significant variation exists in international and national policies regarding the return of research results.
- Pediatric policies are increasingly context-specific, adapting to individual child needs.
- The concept of 'personalized' pediatric policy emphasizes clinical significance and actionability during childhood.
Conclusions:
- The interpretation of 'best interests of the child' is evolving due to genomic advancements.
- Emerging pediatric policies reflect a personalized approach to managing genetic information.
- International collaboration is crucial for developing consistent ethical guidelines in pediatric genomic research.
Abstract:
Decision-making dynamics in pediatric research have their foundation in the principle of the 'best interests of the child'. The introduction of new sequencing technologies and the concomitant debate surrounding the return of research results and incidental findings are, however, challenging the interpretation of this principle. A comparative analysis of international and national approaches to the issue (USA, Canada, France, Spain and the UK) reveals not only the emergence of context-specific pediatric policy in this regard, but one that is 'personalized' to the child - that is, what is clinically significant and actionable during childhood.
Related Concept Videos
Regression Toward the Mean
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

